STAT February 10, 2025
Noël Theodosiou, Yogi Hendlin

A narrow focus on biochemical solutions isn’t working

The life sciences industry is experiencing an identity crisis.

Despite great scientific innovation in the past decade and the highest per capita expenditure on health care in the world, U.S. patients are struggling. Obesity...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Stakeholder Management and Interoperability of Biosimilars
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more
FDA approves first rapid-acting insulin biosimilar for diabetes

Share This Article